期刊文献+

鼠抗人CD3、CD4单克隆抗体治疗肾移植后急性排斥反应的疗效观察 被引量:3

Application of McAb T3 and McAb T4 in patients with renal transplantation
原文传递
导出
摘要 目的 探讨鼠抗人单克隆抗体预防及治疗尸肾移植后排斥反应的效果。方法 总结和分析了62 例肾移植后应用鼠抗人单克隆抗体WuT3 、WuT4 预防及治疗排斥反应的效果、单克隆抗体治疗期间血清游离单克隆抗体水平与受者抗鼠抗体的产生等情况。结果 该抗体对急性排斥反应的总体治愈率为76 .1 % , 对耐激素的难治性排斥反应的逆转率达60 .7 % ; CD3 和CD4 的抑制效应与血清游离单克隆抗体浓度密切相关; 首次应用单克隆抗体治疗时, 抗体的产生与否及量的多少并不影响疗效; 在单克隆抗体治疗的过程中, CD4/CD8 下降明显者, 排斥逆转的可能性大; 停止治疗后T 淋巴细胞亚群未恢复正常水平者, 感染率明显上升。结论 WuT3 、WuT4 对肾移植后急性排斥反应, 包括耐激素急性排斥反应具有较为满意的治疗效果。 Objective To evaluate the efficacy of McAb T3 and McAb T4 in renal graft rejection. Methods The data of 62 case times receiving McAb T3 and McAb T4 for preventing and treating rejection in renal graft recipients were studied retrospectively, including the soluble monoclonal antibody, the humoral antibody response to a murine monoclonal antibody and T lymphocyte subsets. Results The total cured rate for acute rejection was 76.1% . The reverse of steroid resistant rejection was 60.7% . No correlation between preexisting antibodies and the severity of side effects from monoclonal therapy existed. During the treatment of McAb, the rejection reversion was probable in the patients with markedly decrease of CD4/CD8. If the T lymphocyte subsets didn't return to normal, the infectious rate was obviously increased . Conclusion McAb T3 and McAb T4 had satisfactory therapeutic effects on acute rejection following renal transplantation.
出处 《中华器官移植杂志》 CSCD 2000年第1期22-24,共3页 Chinese Journal of Organ Transplantation
关键词 单克隆抗体 肾移植 排斥反应 Antibodies monoclonal Kidney transplantation Graft rejection
  • 引文网络
  • 相关文献

参考文献2

二级参考文献3

  • 1闵志廉,中华器官移植杂志,1988年,9卷,4期,156页
  • 2葛依工,中华医学杂志,1987年,67卷,8期,468页
  • 3史良如,陈善华,王中德,谭向阳,欧阳斌,徐辉,吴晓波,封江南,王志友,孙可芳,赵亚杰.武汉(Wu)系列抗人T细胞及其亚群单抗[J]免疫学杂志,1989(04).

共引文献8

同被引文献23

  • 1蒋金根,简桂花,钮善福.肾移植后肺部弥漫性病变的诊断和治疗[J].上海医科大学学报,1994,21(4):285-288. 被引量:8
  • 2张鹏宇,周新,金先桥,陈宇清,张国清.无创机械通气在肾移植术后重症肺部感染合并急性呼吸衰竭中的应用[J].中国呼吸与危重监护杂志,2006,5(4):260-263. 被引量:10
  • 3黄樱,王红,张淑文,王宝恩.肾移植术后肺炎死亡危险因素探讨[J].中国急救医学,2006,26(8):579-581. 被引量:4
  • 4中华人民共和国卫生部.医院感染诊断标准(试行).北京:中华人民共和国卫生部,2001:10-12.
  • 5Jha R,Narayan G,Jaleel MA,et al.Pulmonary infections after kidney transplantation.J Assoc Physicians India,1999;47:779
  • 6Winston DJ,Wirin D,Shaked A,et al.Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients.Lancet,1995;346:69
  • 7Rubin RH,Ikonen T,Gummet JF,et al.The therapeutic prescription for the organ transplant recipient:the linkage of immunosuppression and antimicrobial strategies.Transpt Infect Dis,1999;1:29
  • 8Akposso K,Rondeau E,Haymann JP,et al.Long-term rognosis of renal transplantation after pre-emptive treatment of cytomegalovirus infection.Transplantation,1997;63:974
  • 9Cainelli F,Vento S.Infections and solid organ transplant rejection:A cause and effect relationship ?[J].Lancet Infect Dis,2002;2(9):539-549.
  • 10Jordan SC,Vo A,Bunnapradist S,et al.Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients:Monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction[J].Am J Transplant,2002;2(7):671-673.

引证文献3

二级引证文献16

;
使用帮助 返回顶部